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http:WHAT THIS PAPER ADDS?
This experimental study is the ﬁrst to our knowledge to show that early impairment of liver mitochondrial
respiration after gut ischaemia/reperfusion (IR) is related to blood lactate levels and that methylene blue (MB)
injection restores liver mitochondria oxidative capacity after gut IR. This observation could have clinical impli-
cations in situations such as gut IR during vascular surgery. If injected before vascular unclamping, MB might
protect liver mitochondria function and minimise the incidence of postoperative multiple organ dysfunction. MB
is already used in many indications (e.g., methaemoglobinaemia) and has been proposed as treatment in
vasoplegic shock during sepsis, cardiopulmonary bypass surgery and liver transplantation.Objectives: Mesenteric ischaemia/reperfusion (IR) may lead to liver mitochondrial dysfunction and multiple
organ failure. We determined whether gut IR induces early impairment of liver mitochondrial oxidative activity
and whether methylene blue (MB) might afford protection.
Design: Controlled animal study.
Materials and methods: Rats were randomised into three groups: controls (n ¼ 18), gut IR group (mesenteric
ischaemia (60 min)/reperfusion (60 min)) (n ¼ 18) and gut IR þ MB group (15 mg kg1 MB intra-peritoneally)
(n ¼ 16). Study parameters were: serum liver function markers, blood lactate, standard histology and DNA
fragmentation (apoptosis) on intestinal and liver tissue, maximal oxidative capacity of liver mitochondria
(state 3) and activity of complexes II, III and IV of the respiratory chain measured using a Clark oxygen
electrode.
Results: Gut IR increased lactate deshydrogenase (þ982%), aspartate and alanine aminotransferases (þ43%
and þ74%, respectively) and lactate levels (þ271%). It induced segmental loss of intestinal villi and cryptic
apoptosis. It reduced liver state 3 respiration by 30% from 50.1  3 to 35.2  3.5 mM O2 min1 g1 (P < 0.01)
and the activity of complexes II, III and IV of the mitochondrial respiratory chain. Early impairment of liver
mitochondrial respiration was related to blood lactate levels (r2 ¼ 0.45). MB restored liver mitochondrial
function.
Conclusions: MB protected against gut IR-induced liver mitochondria dysfunction.
 2012 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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//dx.doi.org/10.1016/j.ejvs.2012.11.011decade.1e3 Gut reperfusion leads to the production of
numerous mediators such as reactive oxygen metabolites,
pro-inﬂammatory cytokines and nitric monoxide and also
activates multiple enzymes.4 Interactions between poly-
morphonuclear neutrophils and endothelial cells would be
instrumental in inducing secondary, inﬂammatory injury to
distant organs. This would be the leading cause of death in
critically ill patients.5
The guteliver axis is thought to play a key role in the
deleterious effects induced by gut ischaemiaereperfusion
O. Collange et al. 169(IR).6 Intestinal circulation is coupled in series with the liver
vasculature, which traps circulating leucocytes activated by
gut IR and, following intestinal ischaemia, Kupffer cells are
the primary source of pro-inﬂammatory cytokine release.7,8
Although gut IR is not characterised by early histological
liver lesions, a subcellular approach might nevertheless
throw light on a role of the liver in the deleterious effects
induced by gut IR.9 The study of liver mitochondria, in
particular, might be useful as mitochondria are the main
energy source in cells and convert nutrients into energy
through cellular respiration.10 Impaired mitochondrial
function is strongly involved in IR physiopathology.11
Methylene blue (MB) is a candidate substance for
reducing the effects of gut IR on remote organs such as the
liver. It is an inexpensive drug used to treat diseases such as
methaemoglobinaemia and Alzheimer’s and has been
proposed for use in vasoplegic shock during sepsis, cardio-
pulmonary bypass surgery and liver transplantation.12 The
only histological study of MB action on the intestine after
gut IR has shown no alleviation of IR-related intestinal
lesions. However, MB is known to enhance key biochemical
pathways in mitochondria, and cycling between oxidised
and reduced MB forms might block oxidant production.13e
15 The aim of this study was to determine, ﬁrst, whether gut
IR induces early impairment of liver mitochondrial function
and, second, whether MB might reduce such impairment.MATERIALS AND METHODS
Experimental design
The study was performed in adult male Wistar rats (330e
380 g) (Depré, Saint Doulchard, France). The rats were
housed at a temperature of 22  2 C, kept on a 12:12-h
photoperiod, and provided with food and water ad libitum.
Procedures were conducted in accordance with the insti-
tutional guidelines for the care and use of laboratory
animals and the study was approved by the institutional
animal care committee of the University of Strasbourg
(CREMEAS authorisation N AL/03/11/06/09).
Fifty-four rats were randomised into three groups: (i)
a gut IR group (n ¼ 18) which underwent gut ischaemia
(60 min) and reperfusion (60 min) by superior mesenteric
artery (SMA) clamping/unclamping and received 2 ml saline
serum intra-peritoneally (IP) 10 min before reperfusion; (ii)
a gut IR þ MB group (n ¼ 16), treated as the gut IR group
but with 15 mg kg1 MB diluted in saline serum before
injection; (iii) a control group (C, n ¼ 18) which underwent
anaesthesia and sham surgery and received 2 ml of saline
serum at a time-point corresponding to 10 min before
reperfusion.Experimental procedures
Anaesthesia was induced and maintained with IP ketamine
(Imalgène 1000, Merial, France). The rats were placed in
a supine position on heating pads to maintain body
temperature at 37 C (rectal temperature probe) and kept
under spontaneous ventilation during the experimentalprocedure. After a midline abdominal incision, the SMA was
isolated at its origin and occluded with an atraumatic clamp
for 60 min. This was followed by reperfusion for 60 min. Gut
IR was conﬁrmed by complete pulse cessation and resto-
ration in the mesenteric arcades and by a change in intes-
tinal colour. Control animals underwent the same protocol
but their SMAs were not occluded.
All tests were performed at the end of reperfusion
(treated groups) or an equivalent time (controls).
Circulating liver function markers and blood lactate
Blood obtained by abdominal aorta puncture was centri-
fuged (3500 g for 15 min) to obtain serum. Serum markers
of liver insult (lactate dehydrogenase (LDH), aspartate and
alanine aminotransferases (AST and ALT)) and markers of
cholestasis (bilirubin and alkaline phosphatase (ALP)) were
measured on a Synchron IR (Beckman-Coulter, Fullerton,
CA, USA) after calibration according to the International
Federation of Clinical Chemistry recommendations. Blood
lactate levels were measured by a micromethod on
a Lactate Pro device (LT1710, Arkray, KGK, Japan).
Standard gut and liver histology and DNA fragmentation
(TUNEL) assay
Fragments of the last ileal loop and liver segment VI (eight
samples) were placed into a buffered formol solution
immediately after harvesting, then processed, embedded in
parafﬁn and sectioned (3e5 mm). A pathologist blinded to
the study protocol analysed the sections under a light
microscope.
For standard histology, tissue sections were stained with
haematoxylineeosin and intestinal tissue injury was graded
according to the Chiu/Park scale:16 Grade 0, normal
mucosa; Grade 1, development of a subepithelial space at
the tips of the villi; Grade 2, more extensive subepithelial
space than in Grade 1; Grade 3, massive epithelial lifting
down the sides of the villi; Grade 4, villi denuded of
epithelium; Grade 5, loss of villi; Grade 6, crypt layer injury;
Grade 7, transmucosal injury; and Grade 8, transmural
infarction.
In the TUNEL (terminal deoxynucleotidyl transferase
dUTP nick end labelling) assay, after parafﬁn removal, the
gut and liver tissue sections from eight samples were
rehydrated in a series of xylene, ethanol and distilled water
baths, rinsed in phosphate buffered saline (PBS) 1, treated
with proteinase K (20 mg ml1) (SIGMA, France) for 15 min
at 37 C, and then incubated for 1 h at 37 C with a mixture
containing deoxynucleotidyltransferase terminal enzyme (In
Situ Cell Death Detection Kit, POD, Roche Diagnostics,
Penzberg, Germany). Incorporated ﬂuorescein was detected
by anti-ﬂuorescein antibody Fab fragments from sheep,
conjugated with horseradish peroxidase (POD) and incu-
bated for 30 min at 37 C.
Lastly, tissue sections were exposed for 10 min to
a peroxidase substrate, rinsed in PBS 1, and counter-
stained with Mayer’s Hemalum (Merck, France). Cells with
brown-coloured nuclei were considered to be apoptotic.
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chain complex analysis
Liver mitochondria were isolated on ice from 8 (IR þ MB
group) or 10 (control and gut IR groups) animals (Fig. 1).
Tissue was placed in isolation buffer A containing 70 mM
sucrose, 210 mM mannitol, 1 mM ethylene glycol tetra-
acetic acid (EGTA) in 50 mM Tris/HCl pH 7.4. The tissue was
ﬁnely minced with scissors and then homogenised in the
same buffer using a Potter Elvejem. The homogenate was
centrifuged at 3000 rpm for 3 min at 4 C and the resultant
supernatant at 10,000 rpm for 10 min at 4 C. The mito-
chondrial pellet was washed in isolation buffer B containing
70 mM sucrose and 210 mM mannitol in 50 mM Tris/HCl pH
7.4 before being re-suspended in this buffer. Aliquots were
then removed for protein measurement by the Bradford
method (Biomate 3, Thermo Fisher Scientiﬁc, Inc.).
Mitochondrial respiration was measured (oxygen
consumption) by methods adapted from a previously
described procedure using a Clark oxygen electrode
(Strathkelvin Instruments Limited, North Lanarkshire, Scot-
land) in a 3 ml volume chamber at 25 C with continuous
stirring of the respiratory medium (100 mM KCl, 50 mM
Mops, 1 mM EGTA, 5 mM Kpi, 0.1% fatty acid-free bovine
serum albumin (BSA) at pH 7.4).17,18,22 Basal oxygen
consumption (‘state 4’) was measured after addition of
glutamateemalate as substrate. Maximal respiration rate
(‘state 3’) was measured after addition of adenosine
diphosphate (ADP), which causes a sudden burst of oxygen
uptake as the diphosphate (ADP) is converted into the
triphosphate (ATP).
The relative contribution of respiratory chain complexes to
the global mitochondrial respiratory rate was measured
by adding speciﬁc blockers and activators. During state 3,Figure 1. Isolation of liver mitochondria and substrates used to meelectrons ﬂow through each of the complexes I, III and IV.
Complex I was blocked with amytal (0.02 mM) and complex II
was stimulated with succinate (25 mM). Under these condi-
tions, oxygen consumption reﬂects the activity of complexes
II, III and IV (state 3þSucc). Then, the artiﬁcial electron donor
N,N,N0,N0-tetramethyl-p-phenylenediaminedihydrochloride
(TMPD) and ascorbate (0.5 mM), which maintains TMPD in
a reduced state, were added. As reduced TMPD donates
electrons to cytochrome c, this enabled determination of the
activity of cytochrome c oxidase (complex IV) alone (state
3þTMPD).
Statistical analysis
Results were expressed as means  standard error of the
mean (SEM). Groups were compared by one-way analysis of
variance (ANOVA) and the Tukey post hoc test. The rela-
tionship between lactate and liver mitochondria parameters
was tested by Pearson correlation and regression analysis.
p-values <0.05 were considered signiﬁcant. Statistical
analysis was performed using GraphPad Prism software
(version 5.03 for Windows) (GraphPad Software, San Diego,
CA, USA).
RESULTS
Liver function tests and blood lactate levels
Gut IR induced liver injury as evidenced by a signiﬁcant
increase in LDH (þ982%, 235  41 vs. 2308  530 UI l1;
P < 0.05), AST (þ43%, 86  10 vs. 199  20 UI l1;
p < 0.05) and ALT (þ74%, 43  1 vs. 158  21 UI l1;
P < 0.05) (Fig. 2). Injury was not associated with cholestasis
as there was no signiﬁcant change in conjugated bilirubin
(1.4  0.2 vs. 1.9  0.2 mmol l1) or in ALP (126  22 vs.asure respiratory chain activity (modiﬁed from Charles et al.33).
Figure 2. Liver function. LDH, lactate deshydrogenase; AST, aspartate aminotransferase; ALT, alanine aminotransferase. Mean  SEM. NS,
not signiﬁcant, *p < 0.05, **p < 0.01.
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liver function tests.
Blood lactate level was signiﬁcantly higher in the IR and
IR þ MB groups (3.3  1 and 3.8  1.9 mmol l1,
respectively) than in controls (1.4  04 mmol l1)
(P < 0.001). The difference in level between the IR and
IR þ MB groups was not signiﬁcant (p ¼ 0.58).Histology and DNA fragmentation
The intestine of control rats was normal with no signs of
ischaemic injury and presented incidental apoptotic cells
which were generally found among the epithelial cells of
the villi tips (Fig. 3). Gut IR induced focal injuries ranging in
grade from 0 (normal mucosa) to 5 (loss of villi) and an
increase in DNA fragmentation in intact mucosal structures,
especially in the crypt layer. The extent of focal injury and
apoptosis was similar in the IR and IR þ MB groups.
The livers of the control and the IR groups showed
normal architecture and cellularity on histological exami-
nation, with no signs of ischaemia or inﬂammation in the IR
group, and rare (<1%) apoptotic hepatocytes in the DNA
fragmentation assay. Histology and DNA fragmentation
results did not differ in the IR and IR þ MB groups (normal
in both).Liver mitochondrial function
Signiﬁcant impairment of liver mitochondrial oxidative
capacity occurred after gut IR (Table 1, Fig. 4). Basal mito-
chondrial respiration (state 4) decreased by 28%, maximal
oxidative capacity (state 3) by 30%, complex II, III and IV
activity (state 3þSucc) by 35% and complex IV activity (state3þTMPD) by 29%. MB treatment restored all these activities
(Table 1, Fig. 4).Relationship between gut IR injury and liver mitochondrial
impairment
To steer clear of any possible interference by MB, the
relationship between liver mitochondrial impairment and
gut insult, as assessed by blood lactate, was investigated
by combining data for the control and IR groups
only. Liver mitochondrial respiration was signiﬁcantly
and inversely correlated with lactate level for state 3
(60  5.1  (0.11  lactates) mM O2 min1 g1, r2 ¼ 0.45,
P ¼ 0.001) (Fig. 5), state 3þsucc (r2 ¼ 0.54, P ¼ 0.002) and
state 3þTMPD (r
2 ¼ 0.45, P ¼ 0.001).
DISCUSSION
In our study, gut IR was characterised by villi necrosis, crypt
apoptosis and increased blood lactate. Gut IR signiﬁcantly
decreased the activity of each complex of the liver mito-
chondrial respiratory chain but these decreases were
counteracted by pharmacological post-conditioning with
MB.
Intestinal histology after gut IR revealed typical focal gut
mucosal necrosis without transmucosal infarction ranging in
grade from 0 (normal) to 5 (loss of villi) within a sample.16
In addition, as already reported, the mucosal cells of the
crypt layer were subject to DNA fragmentation processes.19
These histology and biology data thus conﬁrm that our gut
IR model induced moderate yet signiﬁcant impairment as
can be observed clinically in non-lethal gut IR.
Gut IR increased transaminases and LDH, a marker of
ischaemic damage, but did not affect serum bilirubin nor
Figure 3. Gut histology and apoptosis. Representative small intestines from rats: (AeC) Haematoxylineeosin stained sections (10). (A)
Controls: normal mucosa (grade 0); (B) IR: loss of villi (grade 5); (C) IR þ MB: as in B. (A0eC0) Apoptotic cells in DNA fragmentation assay
(see arrows) (20). (A0) Controls: few apoptotic cells; (B0) IR: apoptosis in all intact villi, particularly in crypt layer; (C0) IR þ MB: as in B0.
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Table 1. Liver mitochondria oxidative capacity and respiratory chain complexes.
Substrates/
Respiratory
chain complexes
Mean O2 consumption
(mM/min/g)
ANOVA
P value
Percent change
P valuea
C vs.
IR
C vs.
IR þ MB
IR vs.
IR þ MB
State 4
(basal)
Glutamateemalate/
IeIIIeIV
4.8  03 3.5  0.2 5.2  0.2 <0.002 27
<0.01
e
> 0.05
þ48
<0.05
State 3
(max)
Glutamateemalate/
IeIIIeIV
50  3 35.2  3.5 49.1  2.7 <0.004 29
<0.01
e
> 0.05
þ39
<0.05
State 3
þSucc
Succinate/
IIeIIIeIV
50  2.4 32.5  3.7 47.3  3.1 <0.001 35
<0.01
e
> 0.05
þ45
<0.01
State 3
þTMPD
TMPD/
IV
67.1  3 47.9  4.2 62.8  3.9 <0.003 29
<0.01
e
> 0.05
þ31
<0.05
Means are given with SEM.
a Tukey post-hoc test.
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80% of patients with ischaemic injury have substantially
elevated LDH (ALT/LDH ratio <1) yet low serum bilirubin.21
Liver subcellular dysfunction may precede histological
lesions after gut IR.11 In our study, gut IR signiﬁcantly
decreased liver maximal oxidative capacity and also
impaired the activity of complexes II, III and IV of the liver
mitochondrial respiratory chain. These results support data
obtained by indirect assessment of mitochondrial function.
Poggetti et al. demonstrated gut IR-induced impairment of
the liver mitochondrial redox state by using serum ace-
toacetate/3-hydroxybutyrate levels as indicator.22 Horie
et al. found that gut IR caused liver cell hypoxia and
mitochondrial impairment by using autoﬂuorescence of a
hepatic pyridine nucleotide (reduced nicotinamide adenine
dinucleotide phosphate, NADH) as an indicator of mito-
chondrial O2 consumption and redox state.
7 Increased
lactate may also signal liver mitochondrial dysfunction. In
our study, blood lactate was inversely correlated with liver
maximal oxidative capacity (r2 ¼ 0.45). In humans,
splanchnic hypoperfusion is correlated with hepatic cellular
damage.23 As decreased oxidative capacity is generally
associated with reduced ATP production and subsequent
organ dysfunction, impairment of liver mitochondrial
respiration during gut IR might contribute towards a poor
prognosis and warrant effective treatment.
We conﬁrmed that MB does not alleviate IR-induced
intestinal lesions.15 However, MB can prevent haemody-
namic instability, base deﬁcit and lung injury after gut or
liver IR.24 It attenuates liver damage in extrahepatic
cholestasis and protects against different types of liver
injury.24,25
We observed no decrease in transaminases on MB
injection, maybe because we chose a moderate dose
(15 mg kg1) with known beneﬁts and no major adverse
effects. MB doses of 2 and 60 mg kg1 had no beneﬁcial
effects in a similar rat model of gut IR whereas 6 and
20 mg kg1 reduced haemodynamic deterioration and
metabolic acidosis.26 During vasoplegic shock, patients
typically receive an intravenous (IV) bolus of 1e2 mg kg1
MB.27,28 A decrease in transaminases might have been
missed because reperfusion time was too short (1 h) withregard to transaminase kinetics in hepatic disease which is
apparently slow.29 Alternatively, MB was perhaps just
unable to normalise transaminases. It should be stressed,
however, that a decrease in aminotransferase levels alone
after a marked increase has no prognostic meaning as both
resolution and massive hepatic necrosis may show a similar
biochemical pattern.30
In our study, MB counteracted the deleterious effects of
gut IR on liver oxidative capacities and restored cellular
energy homeostasis. The underlying mechanisms warrant
study. MB might modulate the nitric oxide (NO)/guanylate
cyclase pathway and reduce oxidative stress and/or might
interact directly with mitochondria.13,14,31 MB passes
through both cellular and mitochondrial membranes,
accumulates within mitochondria and improves mitochon-
drial respiration at low concentrations (0.5e2 mM) by
shuttling electrons to oxygen in the electron transport
chain. MB also counteracts perturbed mitochondrial
metabolism induced by mutagens, acts as an alternative
electron acceptor in mitochondria and might inhibit the
production of superoxide by competing directly with
molecular oxygen.14
Our study has several limitations. First, we used a mild
gut IR model (SMA ischaemia (1 h)/reperfusion (1 h))
simulating certain clinical and surgical situations of gut
suffering (vascular surgery, intestinal surgery, shock.) but
this model cannot be generalised to all situations. An earlier
model using supra-coeliac ischaemia (40 min)/reperfusion
(1 h) was associated with higher intestinal injury (lactate
7.1  1.6 mmol l1).32 One hour of ischaemia was associ-
ated with >50% lethality within the ﬁrst hour of reperfu-
sion (unpublished data). Our present model induced
signiﬁcant histological injury, apoptosis and an increase in
lactate (3.3  1 mmol l1) but was not lethal, and is
moreover the most widely used experimental model.
Second, we used a single MB dose (15 mg kg1 IP) based
on published work.26 This dose restored 100% of liver
mitochondria oxidative capacities and has no known
adverse effects. However, the lowest MB dose that protects
liver mitochondria needs to be determined.We injected MB
10 min before reperfusion because onset of ischaemia is
rarely predictable in clinical practice. MB injection
Figure 5. Relationship between blood lactate and maximal liver
mitochondria oxidative capacity (state 3) for control and IR groups
combined. r2 ¼ 0.48; p ¼ 0.001.
Figure 4. Respiration rates in isolated liver mitochondria. Mito-
chondria isolated from control group (C) (n ¼ 10), IR group
(n ¼ 10), and IR þ MB group (n ¼ 8) with added (A) glutamatee
malate and ADP (state 3), (B) succinate (state 3þSucc), (C) TMPD/
Ascorbate (state 3þTMPD). Mean  SEM. *p < 0.05, **p < 0.01.
174 European Journal of Vascular and Endovascular Surgery Volume 45 Issue 2 February/2013immediately after ischaemia seemed clinically sound and
relevant. Such post-conditioning has been shown to reduce
reperfusion-induced injury on occlusion of other vascular
beds.33
Third, we measured mitochondrial activity after gut IR in
liver only. A multi-organ approach is severely hampered by
the need to extract mitochondria from fresh tissue and
measure oxygen consumption immediately. However, we
used the same protocol as in an earlier study on pulmonary
mitochondria.34 Gut IR induced a 50% decrease in oxidative
capacity in the liver and a 30% decrease in the lung. Finally,
we addressed only a small piece of a complex situation.
In conclusion, the liveregut axis has a key role in the
deleterious effects of gut IR. We have demonstrated early
impairment of the complexes of the liver mitochondrial
respiratory chain after gut IR. MB suppressed this remote
impairment. If injected before vascular unclamping in
a clinical setting, MB might protect liver mitochondria
function and minimise the incidence of postoperative
multiple organ failure. Clinical studies on how to best use
MB to limit the deleterious effects of gut IR during vascular
surgery are thus warranted.
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